or MRA (mineralocorticoid receptor antagonists) had between 36 and 38% higher risk of heart-related death or hospitalization ...

A multicenter study by the PIOPED III Investigators has shown that magnetic resonance angiography (MRA) can be used to detect pulmonary embolism. The proportion of technically inadequate images ...

Bayer has filed its mineralocorticoid receptor antagonist (MRA) finerenone as a treatment for a common form of heart failure in the EU, fulfilling a key 2025 pipeline objective. The pharma group ...